United States Biotechnology & Medical Research

CAMP4 Therapeutics Corp (CAMP)

Track

The most recent insider trading activity at CAMP4 Therapeutics Corp occurred on September 11, 2025. On this date, multiple insiders and affiliated entities, including the CEO, CFO, and CMO, executed significant buy transactions. These purchases followed a series of similar acquisition activities by various stakeholders recorded on October 15, 2024.
Ticker: CAMP Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 11 Sep 2025
Value US$358,109.25 | Price 298.05 | Shares 50,552 (+44.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-15 2025-09-11 B Purchase
2.6
5AM Partners VI, LLC
Large shareholder
50,552 +44.9%
298.05
US$358,109 		50,552 +44.9% 298.05 US$358,109
2025-09-11 2025-09-11 B Purchase
1.9
Polaris Management Co. VII, L.L.C.
Large shareholder
12,204 +46.8%
380.60
US$850,181 		12,204 +46.8% 380.60 US$850,181
2025-09-11 2025-09-11 B Purchase
1.9
Polaris Management Co. VII, L.L.C.
Large shareholder
33,471 -30.2%
200.69
US$4,559,939 		33,471 -30.2% 200.69 US$4,559,939
2025-09-11 2025-09-11 B Purchase
2.5
Nashat Amir
Non-Executive Director Large shareholder
85,468 +76.2%
1.53
US$130,766 		85,468 +76.2% 1.53 US$130,766
2025-09-11 2025-09-11 B Purchase
2.5
Nashat Amir
Non-Executive Director Large shareholder
1,221,721 +76.2%
1.53
US$1,869,233 		1,221,721 +76.2% 1.53 US$1,869,233
2025-09-11 2025-09-11 B Purchase
Maricich Yuri

Chief Medical Officer

Officer
6,060 +inf%
1.65
US$9,999 		6,060 +inf% 1.65 US$9,999
2025-09-11 2025-09-11 B Purchase
Mandel-Brehm Josh

Chief Executive Officer

Executive Director
6,060 +2.2%
1.65
US$9,999 		6,060 +2.2% 1.65 US$9,999
2025-09-11 2025-09-11 B Purchase
Young Richard A
Non-Executive Director
15,151 +9.8%
1.65
US$24,999 		15,151 +9.8% 1.65 US$24,999
2025-09-11 2025-09-11 B Purchase
Gold Kelly

Chief Financial Officer

Officer
6,060 +9.8%
1.65
US$9,999 		6,060 +9.8% 1.65 US$9,999
2024-10-17 2024-10-15 B Purchase
0.5
AH Equity Partners Bio I, L.L.C.
Large shareholder
545,454 +inf%
11.00
US$5,999,994 		545,454 +inf% 11.00 US$5,999,994
2024-10-17 2024-10-15 B Purchase
0.5
AH Equity Partners Bio I, L.L.C.
Large shareholder
181,818 +13.0%
11.00
US$1,999,998 		181,818 +13.0% 11.00 US$1,999,998
2024-10-17 2024-10-15 B Purchase
0.5
Northpond Ventures II GP, LLC
Large shareholder
763,636 +inf%
11.00
US$8,399,996 		763,636 +inf% 11.00 US$8,399,996
2024-10-17 2024-10-15 B Purchase
1.4
Enavate Sciences GP, LLC
Large shareholder
1,363,636 +56.3%
11.00
US$14,999,996 		1,363,636 +56.3% 11.00 US$14,999,996
2024-10-15 2024-10-15 B Purchase
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
909,090 +53.0%
11.00
US$9,999,990 		909,090 +53.0% 11.00 US$9,999,990
2024-10-15 2024-10-15 B Purchase
2.5
Nashat Amir
Non-Executive Director Large shareholder
909,090 +inf%
11.00
US$9,999,990 		909,090 +inf% 11.00 US$9,999,990
2024-10-15 2024-10-15 B Purchase
1.9
Polaris Management Co. VII, L.L.C.
Large shareholder
909,090 +inf%
11.00
US$9,999,990 		909,090 +inf% 11.00 US$9,999,990
2024-10-15 2024-10-15 B Purchase
2.6
5AM Partners VI, LLC
Large shareholder
909,090 +53.0%
11.00
US$9,999,990 		909,090 +53.0% 11.00 US$9,999,990
Explore more

More insider trading research around CAMP4 Therapeutics Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America